The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review
about
Sudden unexpected death related to enterovirus myocarditis: histopathology, immunohistochemistry and molecular pathology diagnosis at post-mortemCanadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trialsVeno-arterial extracorporeal membrane oxygenation for cardiogenic shock due to myocarditis in adult patientsInflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and TreatmentAcute viral myocarditisValue of The Wearable Cardioverter Defibrillator (WCD) as a Bridging-Therapy before Implantation of a Cardioverter Defibrillator (ICD)2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theEffect of lovastatin on coxsackievirus B3 infection in human endothelial cellsDocetaxel induced cardiotoxicity[102 patients with suspected myocarditis : Clinical presentation, diagnostics, therapy and prognosis].Injectable collagen implant improves survival, cardiac remodeling, and function in the early period after myocarditis in rats.The emerging clinical role of cardiovascular magnetic resonance imaging.Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis.Towards risk factor assessment in inflammatory dilated cardiomyopathy: the SFB/TR 19 study.NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy.Increased risk of ventricular tachycardia and cardiovascular death in patients with myocarditis during the long-term follow-up: A national representative cohort from the National Health Insurance Research Database.Histopathological diagnosis of myocarditis in a dengue outbreak in Sri Lanka, 2009.Coxsackievirus B detection in cases of myocarditis, myopericarditis, pericarditis and dilated cardiomyopathy in hospitalized patientsPrognostic value of contrast-enhanced cardiac magnetic resonance imaging in patients with newly diagnosed non-ischemic cardiomyopathy: cohort study.Increased systemic Th17 cytokines are associated with diastolic dysfunction in children and adolescents with diabetic ketoacidosisSelective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathyRenin angiotensin system inhibition is associated with reduced free radical concentrations in arteries of patients with coronary heart disease.Strong prognostic value of combining N-terminal atrial natriuretic peptide and ECG to predict death in heart patients from general practice.Implementation of the NICE guidelines for the primary prevention of mortality from ventricular tachyarrhythmias: implications for UK electrophysiology centres; activity modelling from the UK-HEART study.Molecular mechanisms behind progressing chronic inflammatory dilated cardiomyopathyBenserazide, the first allosteric inhibitor of Coxsackievirus B3 3C protease.Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives.Heart Failure in Chronic Myocarditis: A Role for microRNAs?Myocarditis in Patients With Antisynthetase Syndrome: Prevalence, Presentation, and Outcomes.Myocarditis: early biopsy allows for tailored regenerative treatmentEndomyocardial biopsy in patients with cardiomyopathy of unknown origin: does specialized center experience apply to a tertiary care hospital?Coxsackievirus-induced myocarditis: new trends in treatment.Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditisInflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis?Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy.A Novel Murine Model of Parvovirus Associated Dilated Cardiomyopathy Induced by Immunization with VP1-Unique Region of Parvovirus B19.Myocarditis: diagnosis and treatment.Myocardial recovery and the failing heart: myth, magic, or molecular target?Role of endomyocardial biopsy for children presenting with acute systolic heart failure.Regulation of the immune response during infectious myocarditis.
P2860
Q24632464-F5B30B72-83F8-41EC-AB3E-F76AB8A7891DQ24650348-4CFD1A18-9146-4E1F-BF82-9FE47EEF009EQ26738599-572C8258-C6C4-4F5B-AA16-1D9C35A82574Q26744257-ECEB291A-B7D0-4369-A906-E896F92989E2Q27486698-83970614-4127-45FF-9BC0-C49515F96815Q28067809-16AA10DB-AAE9-4D4C-AD9D-A9BBB4BD320CQ28087002-065A0A73-F8D1-457A-9A97-525E5706DEB2Q28303547-CA41E3AC-1806-4754-A08F-18D189EB541DQ28343995-05D105AC-9220-4291-AB74-378E8A5D6A8AQ30313532-74796936-0D48-4C16-9D89-85193DD6E801Q30457510-7AAFC5DA-D373-49F8-96C8-084C6057436BQ30475257-1BC620B6-B22A-4876-AEED-2D7457C83F12Q30573820-C3D1B0FF-B25F-4D48-99FD-69106129AB6BQ33302094-4E117AC7-D76A-4287-AEBD-2001DA86860BQ33340287-9C239802-5B0A-45AC-A131-514A97A3515CQ33644095-C38873F3-AF92-46DE-BF07-85491D06E089Q33974343-4404116C-B365-4B5A-B42E-C4C1A5D6E1ADQ34042122-CDE9F93E-B3E0-477F-9EA6-996E20FB2627Q34600002-184385B3-F794-4724-838A-82B9E46A5E65Q34981029-9822582A-74C0-48FC-8AC8-14DDC12B92C5Q35071386-5302CEE3-CBB8-4484-897D-A1F81AB070DAQ35380233-D86955AB-F68B-4C91-823A-F7CCF8BE7A9EQ35380284-D1A83A26-FAA6-4A05-B76A-BAC69A8970ECQ35380439-01EAF6D8-301C-4DFE-A694-B5DE36971781Q35608214-08B3B7AC-9078-4673-B9EC-0DAFCA78F510Q35645639-CC34F624-9947-4DA8-A3AF-84179DED39C3Q35706837-A1C1DAC1-392E-4EC2-9CB3-91826B7B1C5EQ35742151-BD17B48D-16FC-4181-9810-3B688DB69971Q35857842-5C46D962-C2AF-4DED-B743-8D8F96E65CE5Q36017504-13B2093B-3157-479D-A18F-41696F3C59A4Q36159917-144710FF-5076-42DF-B06F-6E2E4A2F3FE5Q36233532-4E0AD78C-8FEA-4A43-AF57-91672F243DD7Q36370549-A5919A01-999B-4B99-919D-4D21722B7E10Q36560495-2C3E1B34-35B6-494D-9327-97C195C164A7Q36990126-A12E8ED8-6BBC-4E67-BA1D-CC0DAECBB91DQ37366530-10476D1A-BC5C-43A1-9B83-ECFEF375941FQ38038540-CFFB5207-7E55-4C86-B6B9-140A1EFBBA7CQ38060345-8DFFAB7C-4240-488C-98B2-55ED4D00DD7CQ38161315-45B2ED6A-EC5B-4256-A6C1-C3D1CBFDD1EAQ38180743-FD67E975-5688-42A8-97A8-E5C8F5476E2C
P2860
The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The fate of acute myocarditis ...... lated cardiomyopathy: a review
@ast
The fate of acute myocarditis ...... lated cardiomyopathy: a review
@en
The fate of acute myocarditis ...... lated cardiomyopathy: a review
@nl
type
label
The fate of acute myocarditis ...... lated cardiomyopathy: a review
@ast
The fate of acute myocarditis ...... lated cardiomyopathy: a review
@en
The fate of acute myocarditis ...... lated cardiomyopathy: a review
@nl
prefLabel
The fate of acute myocarditis ...... lated cardiomyopathy: a review
@ast
The fate of acute myocarditis ...... lated cardiomyopathy: a review
@en
The fate of acute myocarditis ...... lated cardiomyopathy: a review
@nl
P2093
P2860
P356
P1433
P1476
The fate of acute myocarditis ...... lated cardiomyopathy: a review
@en
P2093
D'Ambrosio A
Di Lenarda A
Di Sciascio G
Silvestri F
P2860
P304
P356
10.1136/HEART.85.5.499
P407
P577
2001-05-01T00:00:00Z